Annual SGA
$30.02 M
-$12.83 M-29.94%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual SGA is $30.02 million, with the most recent change of -$12.83 million (-29.94%) on December 31, 2023.
- During the last 3 years, CTMX annual SGA has fallen by -$6.01 million (-16.69%).
- CTMX annual SGA is now -29.94% below its all-time high of $42.85 million, reached on December 31, 2022.
Performance
CTMX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.95 M
-$442.00 K-5.27%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly SGA is $7.95 million, with the most recent change of -$442.00 thousand (-5.27%) on September 30, 2024.
- Over the past year, CTMX quarterly SGA has increased by +$1.14 million (+16.73%).
- CTMX quarterly SGA is now -32.30% below its all-time high of $11.75 million, reached on June 30, 2022.
Performance
CTMX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.86 B
+$13.83 M+0.48%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM SGA is -$2.86 billion, with the most recent change of +$13.83 million (+0.48%) on September 30, 2024.
- Over the past year, CTMX TTM SGA has dropped by -$2.89 billion (-8965.25%).
- CTMX TTM SGA is now -3559.87% below its all-time high of -$78.14 million.
Performance
CTMX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CTMX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.9% | +16.7% | -8965.3% |
| 3 y3 years | -16.7% | +16.7% | -8965.3% |
| 5 y5 years | -10.4% | +16.7% | -8965.3% |
CTMX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | at low | -32.3% | +16.7% | -37.4% | +1.4% |
| 5 y | 5-year | -29.9% | at low | -32.3% | +16.7% | -92.4% | +1.4% |
| alltime | all time | -29.9% | +505.9% | -32.3% | +443.6% | -3559.9% | +1.4% |
CytomX Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.95 M(-5.3%) | $31.93 M(+3.7%) |
| Jun 2024 | - | $8.39 M(+8.3%) | $30.79 M(+3.3%) |
| Mar 2024 | - | $7.75 M(-0.9%) | $29.80 M(-0.7%) |
| Dec 2023 | $30.02 M(-29.9%) | $7.83 M(+14.9%) | $30.02 M(-6.9%) |
| Sep 2023 | - | $6.81 M(-7.9%) | $32.26 M(-10.2%) |
| Jun 2023 | - | $7.40 M(-7.2%) | $35.94 M(-10.8%) |
| Mar 2023 | - | $7.98 M(-20.8%) | $40.28 M(-6.0%) |
| Dec 2022 | $42.85 M(+9.4%) | $10.07 M(-4.0%) | $42.85 M(+1.4%) |
| Sep 2022 | - | $10.49 M(-10.7%) | $42.24 M(-1.4%) |
| Jun 2022 | - | $11.75 M(+11.4%) | $42.83 M(+5.8%) |
| Mar 2022 | - | $10.54 M(+11.5%) | $40.48 M(+3.4%) |
| Dec 2021 | $39.16 M(+8.7%) | $9.46 M(-14.7%) | $39.16 M(+0.8%) |
| Sep 2021 | - | $11.09 M(+18.0%) | $38.85 M(+6.7%) |
| Jun 2021 | - | $9.39 M(+1.8%) | $36.40 M(+2.0%) |
| Mar 2021 | - | $9.23 M(+0.9%) | $35.69 M(-1.0%) |
| Dec 2020 | $36.03 M(-2.0%) | $9.14 M(+5.9%) | $36.03 M(-0.2%) |
| Sep 2020 | - | $8.63 M(-0.5%) | $36.10 M(+0.5%) |
| Jun 2020 | - | $8.68 M(-9.3%) | $35.93 M(-2.0%) |
| Mar 2020 | - | $9.57 M(+3.9%) | $36.66 M(-0.3%) |
| Dec 2019 | $36.77 M | $9.22 M(+8.9%) | $36.77 M(+0.7%) |
| Sep 2019 | - | $8.46 M(-10.1%) | $36.52 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $9.41 M(-2.7%) | $36.20 M(+1.0%) |
| Mar 2019 | - | $9.67 M(+7.8%) | $35.83 M(+6.9%) |
| Dec 2018 | $33.51 M(+30.9%) | $8.97 M(+10.3%) | $33.51 M(+4.2%) |
| Sep 2018 | - | $8.14 M(-10.0%) | $32.15 M(+6.2%) |
| Jun 2018 | - | $9.04 M(+22.9%) | $30.26 M(+11.0%) |
| Mar 2018 | - | $7.36 M(-3.4%) | $27.27 M(+6.5%) |
| Dec 2017 | $25.61 M(+28.8%) | $7.62 M(+21.9%) | $25.61 M(+10.6%) |
| Sep 2017 | - | $6.25 M(+3.3%) | $23.14 M(+5.5%) |
| Jun 2017 | - | $6.05 M(+6.3%) | $21.93 M(+6.8%) |
| Mar 2017 | - | $5.69 M(+10.4%) | $20.52 M(+3.3%) |
| Dec 2016 | $19.87 M(+58.3%) | $5.15 M(+2.4%) | $19.87 M(+6.1%) |
| Sep 2016 | - | $5.03 M(+8.3%) | $18.73 M(+5.5%) |
| Jun 2016 | - | $4.65 M(-7.8%) | $17.75 M(+13.4%) |
| Mar 2016 | - | $5.04 M(+25.7%) | $15.65 M(+24.6%) |
| Dec 2015 | $12.56 M(+92.0%) | $4.01 M(-1.0%) | $12.56 M(+17.0%) |
| Sep 2015 | - | $4.05 M(+58.7%) | $10.73 M(+31.8%) |
| Jun 2015 | - | $2.55 M(+31.1%) | $8.14 M(+45.7%) |
| Mar 2015 | - | $1.95 M(-10.8%) | $5.59 M(+53.4%) |
| Dec 2014 | $6.54 M(+32.0%) | $2.18 M(+49.1%) | $3.64 M(+149.1%) |
| Sep 2014 | - | $1.46 M | $1.46 M |
| Dec 2013 | $4.95 M | - | - |
FAQ
- What is CytomX Therapeutics annual SGA?
- What is the all time high annual SGA for CytomX Therapeutics?
- What is CytomX Therapeutics annual SGA year-on-year change?
- What is CytomX Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly SGA year-on-year change?
- What is CytomX Therapeutics TTM SGA?
- What is the all time high TTM SGA for CytomX Therapeutics?
- What is CytomX Therapeutics TTM SGA year-on-year change?
What is CytomX Therapeutics annual SGA?
The current annual SGA of CTMX is $30.02 M
What is the all time high annual SGA for CytomX Therapeutics?
CytomX Therapeutics all-time high annual SGA is $42.85 M
What is CytomX Therapeutics annual SGA year-on-year change?
Over the past year, CTMX annual SGA has changed by -$12.83 M (-29.94%)
What is CytomX Therapeutics quarterly SGA?
The current quarterly SGA of CTMX is $7.95 M
What is the all time high quarterly SGA for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly SGA is $11.75 M
What is CytomX Therapeutics quarterly SGA year-on-year change?
Over the past year, CTMX quarterly SGA has changed by +$1.14 M (+16.73%)
What is CytomX Therapeutics TTM SGA?
The current TTM SGA of CTMX is -$2.86 B
What is the all time high TTM SGA for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM SGA is -$78.14 M
What is CytomX Therapeutics TTM SGA year-on-year change?
Over the past year, CTMX TTM SGA has changed by -$2.89 B (-8965.25%)